The two boards, a Scientific Advisory Board and Clinical Advisory Board, met with the HBP leadership for the first time this month.

The HBP’s Scientific Research Director Katrin Amunts said it was fantastic to welcome them to the project.

“These are amazing boards with highly renowned experts. The project is committed to building a sustainable network of researchers and infrastructure and we believe the two new boards will help achieve this.”

The boards will provide the HBP with critical and constructive independent and expert advice on its performance and plans. Amunts says this advice will be an important input for long term goals and strategy, as well as future work plans.

The boards will also contribute to project reviews and act as multipliers to improve the visibility of the HBP in the scientific community and the public.

The Scientific Advisory Board consists of eight men and two women, while the Clinical Advisory Board is made up of two women and four men. Members of the two boards are drawn from research facilities in Europe, Japan, Israel and the United States.